Trump: I looked at one hell of a beautiful ass before, Nicki Minaj. That's hard to miss. Stand up.

Oshelu no be your mate 😂😂😂😂😂 SRJ omo ogbon!!!

A student has been expelled from the Nigerian Law School, Yola Campus, for engaging in physical alterations.

Wow. MPOWER shut down?? This is the most dire time to be an international student in the US, especially if you are not on full scholarship. Even then, the scholarship is mostly contingent on your grad advisor or some extramural funding. All those channels are very shaky at the moment. I think it’s pertinent we create a support group to help students caught in both immigration and funding crossfire get beyond the finish line.

If you can give, thank you. If you can’t, a share means so much. GoFundMe: gofund.me/5a7dcc6ce OR GTB: 0478643988 Marvellous Inioluwa Oluwadare #FundDrMarvellous

Hi everyone, I’m Marvellous, some of you know me as Ini. I’m a few months from finishing my MPH at NYU. I planned for this year with a student loan and a summer internship but it didn’t come through. Then this month, MPOWER shut down. I was on their waitlist. #FundDrMarvellous

My hot take this morning for the ladies is that N500k for makeup is financial irresponsibility (I don't care what your financial status is). Invest in treasury bills instead 🫵 END.

Each time I read exchanges between healthcare professionals on X, I can’t help feeling saddened by how easily professional disagreements degenerate into unnecessary contests of superiority. Lately, I’ve come across posts dismissing bioequivalence and insisting on the use of innovator brands. What bothers me is not that professionals have different opinions or preferences, but how quickly these discussions descend into classism, condescension, and a contest over who knows more or occupies a higher pedestal. Two truths can coexist. Someone may reasonably prefer a brand they have used and trusted over the years. However, personal experience can also introduce bias, potentially leading to the hasty generalisation that bioequivalence is a myth. In Canada, for instance, prescriptions for branded medications can be sent to pharmacies with an indication that therapeutic substitution is permitted. If brand preference and therapeutic substitution can coexist within a healthcare system, why must Nigeria’s own conversation be so different? Rather than channel this energy into advocating for stronger quality control, effective pharmacovigilance, and stricter regulation of medicines circulating in Nigeria, some healthcare professionals seem more invested in tearing one another down. We can acknowledge legitimate concerns about medicine quality without dismissing established scientific principles. We can prefer certain brands based on experience without generalising that all generic medicines are inferior. The real issue should be ensuring that every medicine circulating in Nigeria meets the required standards of quality, safety, and efficacy, not proving who can afford the most expensive brand or who has the intellectual upper hand. Our healthcare system needs collective advocacy, evidence-based discussions, and professional solidarity, not superiority contests. We have bigger problems to solve.

Hammers and birds dey gather play dice and enjoy for party.. Members for street Dey count scores for another party. Oye Olohun

GSK produced Augmentin 500mg and later introduced Clavulin, a more affordable generic alternative for those who couldn’t afford Augmentin. It was presented as a subsidised option. The same GSK produced Zinnat and later introduced Proximexa 500mg, a more affordable alternative for those who couldn’t afford Zinnat. One company, producing both innovator brands and more affordable alternatives. If, in this day and age, you still believe price and quality are directly proportional in every circumstance, you will be misled. Price alone is not a reliable measure of quality. You have to look beyond the price tag and understand the product, its manufacturer, quality standards and available evidence.